<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">evrazkar</journal-id><journal-title-group><journal-title xml:lang="ru">Евразийский Кардиологический Журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Eurasian heart journal</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2225-1685</issn><issn pub-type="epub">2305-0748</issn><publisher><publisher-name>Евразийская ассоциация кардиологов</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.38109/2225-1685-2017-4-4-15</article-id><article-id custom-type="elpub" pub-id-type="custom">evrazkar-254</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL PAPERS</subject></subj-group></article-categories><title-group><article-title>ФОРМА КАЛЬЦИЙ-ФОСФАТНЫХБИОНОВ ОПРЕДЕЛЯЕТ ВЫРАЖЕННОСТЬ ВЫЗЫВАЕМОГО ИМИ ПРОАТЕРОСКЛЕРОТИЧЕСКОГО СДВИГА ПРОФИЛЯ СЕКРЕТИРУЕМЫХ ЭНДОТЕЛИАЛЬНЫМИ КЛЕТКАМИ ЦИТОКИНОВ</article-title><trans-title-group xml:lang="en"><trans-title>SHAPE OF CALCIUM PHOSPHATE BIONS DEFINES A PROATHEROSCLEROTIC SHIFT IN CYTOKINE SECRETION PROFILE OF ENDOTHELIAL CELLS</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кутихин</surname><given-names>А. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Kutikhin</surname><given-names>A. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кандидат медицинских наук, старший научный сотрудник лаборатории геномной медицины отдела экспериментальной и клинической кардиологии</p><p>650002, Российская Федерация, г. Кемерово, Сосновый бульвар, д. 6,</p><p>тел.: +7 (3842) 64-41-56</p></bio><bio xml:lang="en"><p>MD, PhD, Senior Researcher, Laboratory for Genomic Medicine, Division of Experimental and Clinical Cardiology</p><p>650002, Russian Federation, Kemerovo, Sosnovy Bulvar, 6</p><p>tel.: +7 (3842) 64-41-56</p></bio><email xlink:type="simple">antonkutikhin@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Великанова</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Velikanova</surname><given-names>E. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кандидат биологических наук, научный сотрудник лаборатории клеточных технологий отдела экспериментальной и клинической кардиологии </p><p>650002, Российская Федерация, г. Кемерово, Сосновый бульвар, д. 6</p></bio><bio xml:lang="en"><p>PhD, Researcher, Laboratory for Cell Technologies, Division of Experimental and Clinical Cardiology</p><p>650002, Russian Federation, Kemerovo, Sosnovy boulevard, 6</p></bio><email xlink:type="simple">velikanova_ea@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шишкова</surname><given-names>Д. К.</given-names></name><name name-style="western" xml:lang="en"><surname>Shishkova</surname><given-names>D. K.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Младший научный сотрудник лаборатории новых биоматериалов отдела экспериментальной и клинической кардиологии </p><p>650002, Российская Федерация, г. Кемерово, Сосновый бульвар, д. 6,</p><p>тел.: +7 (3842) 64-45-27</p></bio><bio xml:lang="en"><p>Junior Researcher, Laboratory for Novel Biomaterials, Division of Experimental and Clinical Cardiology</p><p>650002, Russian Federation, Kemerovo, Sosnovy boulevard, 6</p><p>tel.: +7 (3842) 64-45-27</p></bio><email xlink:type="simple">shishkovadk@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ «Научно-исследовательский институт комплексных проблем сердечно-сосудистых заболеваний»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Research Institute for Complex Issues of Cardiovascular Diseases</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2017</year></pub-date><pub-date pub-type="epub"><day>30</day><month>12</month><year>2017</year></pub-date><volume>0</volume><issue>4</issue><fpage>4</fpage><lpage>15</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Кутихин А.Г., Великанова Е.А., Шишкова Д.К., 2017</copyright-statement><copyright-year>2017</copyright-year><copyright-holder xml:lang="ru">Кутихин А.Г., Великанова Е.А., Шишкова Д.К.</copyright-holder><copyright-holder xml:lang="en">Kutikhin A.G., Velikanova E.A., Shishkova D.K.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.heartj.asia/jour/article/view/254">https://www.heartj.asia/jour/article/view/254</self-uri><abstract><sec><title>Цель исследования</title><p>Цель исследования. Изучить влияние формы кальций-фос-фатных бионов (КФБ) на их эндотелиотоксичность путем оценки профиля секретируемых эндотелиальными клетками проатеросклеротических цитокинов под воздействием КФБ игольчатой формы (ИКФБ) и КФБ сферической формы (СКФБ).</p></sec><sec><title>Материал и методы</title><p>Материал и методы. Для экспериментов была использована культура иммортализованных венозных эндотелиальных клеток человека линии EA.hy 926, которые были рассажены в 6-луночные планшеты (3*105 клеток) с последующим: 1) добавлением через 1 ч 100 мкл СКФБ, ИКФБ или чистого фосфатно-солевого буфера (ФСБ) и дальнейшим культивированием в течение 24 ч (разреженная клеточная модель); 2) культивированием в течение 44 ч и дальнейшим добавлением 100 мкл СКФБ, ИКФБ или ФСБ с продолжением культивирования в течение 4 ч (конфлюэнтная клеточная модель). Далее в надосадке с клеточных культур (n=11 лунок на группу) методом иммуноферментного анализа измерялся уровень секретируемых клетками проатеросклеротических цитокинов (интерлейкина (IL)-1 ß, IL-6, IL-8, IL-10, IL-12, IL-23, фактора некроза опухоли (TNF)-a, интерферона (IFN)-y и растворимой молекулы адгезии сосудистых клеток (sVCAM)-1).</p></sec><sec><title>Результаты</title><p>Результаты. На разреженной клеточной модели экспозиция ИКФБ существенно повышала концентрацию ряда проатеросклеротических цитокинов (IL-1 ß, IL-10, IL-12, IL-23, IFN-y) в сравнении как с экспозицией СКФБ, так и с контрольными клетками. На конфлюэнтной клеточной модели экспозиция обоим типам КФБ значительно снижала уровень секретируемых IL-1 ß, IL-10 и IFN-y, однако их концентрация при экспозиции ИКФБ была выше, чем при экспозиции СКФБ. Методы многомерного статистического анализа на обеих клеточных моделях подтвердили, что профиль секреции цитокинов под воздействием ИКФБ значимо отличен от такового под воздействием СКФБ и далек от профиля контрольных клеток.</p></sec><sec><title>Заключение</title><p>Заключение. ИКФБ вызывают увеличение выделения ряда проатеросклеротических цитокинов эндотелиальными клетками в сравнении с СКФБ, что свидетельствует о большей эндотелиотоксичности ИКФБ.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Study aim</title><p>Study aim. To investigate whether the shape of calcium phosphate bions (CPB) affects their endothelial toxicity via evaluating the cytokine secretion profile of endothelial cells upon the exposure to either spherical or spindle-shaped CPB.</p></sec><sec><title>Material and methods</title><p>Material and methods. For the experiments, we used an immortalized human vein endothelial cell line EA.hy 926. Cells were seeded into 6-well plates (3*105 cells) with the further: 1) addition of 100 |jL either spherical CPB, spindle-shaped CPB, or 1x phosphate buffered saline (PBS) upon 1 h following culture for 24 h (non-confluent cell culture); 2) culture for 44 h and subsequent addition of 100 jL either spherical CPB, spindle-shaped CPB, or PBS following culture for 4 h (confluent cell culture). Upon the collection of cell culture supernatant (n=11 wells per group), the levels of proatherosclerotic cytokines (interleukin (IL)-1ß, IL-6, IL-8, IL-10, IL-12, IL-23, tumor necrosis factor (TNF)-a, interferon (IFN)-y, and soluble vascular cell adhesion molecule (sVCAM)-1) were measured utilizing an enzyme-linked immunosorbent assay.</p></sec><sec><title>Results</title><p>Results. In a non-confluent cell culture, exposure to spindleshaped CPB increased the secretion of several proatherosclerotic cytokines (IL-1 ß, IL-10, IL-12, IL-23, IFN-y) compared to either spherical CPB-treated or control cells. In a confluent cell culture, exposure to either of CPB types decreased the release of IL-1 ß, IL- 10, and IFN-y; however, their concentration was still higher upon the exposure to spindle-shaped CPB in comparison with exposure to spherical CPB. Discriminant analysis and principal component analysis demonstrated that the cytokine secretion profile of spindle-shaped CPB-treated endothelial cells significantly differed from those of either spherical CPB-treated or control cells.</p></sec><sec><title>Conclusion</title><p>Conclusion. Spindle-shaped CPB induce the secretion of proatherosclerotic cytokines by endothelial cells compared to spherical CPB; this suggests higher endothelial toxicity of spindleshaped CPB.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>атеросклероз</kwd><kwd>триггеры</kwd><kwd>бионы</kwd><kwd>эндотелиальные клетки</kwd><kwd>эндотелий</kwd><kwd>воспаление</kwd><kwd>цитокины</kwd><kwd>цитокино-вый профиль</kwd><kwd>интерлейкин-6</kwd><kwd>интерлейкин-8</kwd></kwd-group><kwd-group xml:lang="en"><kwd>atherosclerosis</kwd><kwd>triggers</kwd><kwd>bions</kwd><kwd>endothelial cells</kwd><kwd>endothelium</kwd><kwd>inflammation</kwd><kwd>cytokines</kwd><kwd>cytokine secretion profile</kwd><kwd>interleukin-6</kwd><kwd>interleukin-8</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Wu C.Y., Young L., Young D. et al. Bions: a family of biomimetic mineralo-organic complexes derived from biological fluids. PLoS One. 2013. Vol. 8. No. 9. P. e75501. doi: 10.1371/ journal.pone.0075501.</mixed-citation><mixed-citation xml:lang="en">Wu C.Y., Young L., Young D. et al. Bions: a family of biomimetic mineralo-organic complexes derived from biological fluids. PLoS One. 2013. Vol. 8. No. 9. P. e75501. doi: 10.1371/ journal.pone.0075501.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Price P.A., Thomas G.R., Pardini A.W. et al. Discovery of a high molecular weight complex of calcium, phosphate, fetuin, and matrix gamma-carboxyglutamic acid protein in the serum of etidronate-treated rats. J. Biol. Chem. 2002. Vol. 277. No. 6. P. 3926-3934. doi: 10.1074/jbc.M106366200.</mixed-citation><mixed-citation xml:lang="en">Price P.A., Thomas G.R., Pardini A.W. et al. Discovery of a high molecular weight complex of calcium, phosphate, fetuin, and matrix gamma-carboxyglutamic acid protein in the serum of etidronate-treated rats. J. Biol. Chem. 2002. Vol. 277. No. 6. P. 3926-3934. doi: 10.1074/jbc.M106366200.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Jahnen-Dechent W., Heiss A., Schäfer C., Ketteler M. Fetuin-A regulation of calcified matrix metabolism. Circ. Res. 2011. Vol. 108. No. 12. P. 1494-1509. doi: 10.1161/ CIRCRESAHA.110.234260.</mixed-citation><mixed-citation xml:lang="en">Jahnen-Dechent W., Heiss A., Schäfer C., Ketteler M. Fetuin-A regulation of calcified matrix metabolism. Circ. Res. 2011. Vol. 108. No. 12. P. 1494-1509. doi: 10.1161/ CIRCRESAHA.110.234260.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Wong T.Y., Wu C.Y., Martel J. et al. Detection and characterization of mineralo-organic nanoparticles in human kidneys. Sci. Rep. 2015. Vol. 5. P. 15272. doi: 10.1038/ srep15272.</mixed-citation><mixed-citation xml:lang="en">Wong T.Y., Wu C.Y., Martel J. et al. Detection and characterization of mineralo-organic nanoparticles in human kidneys. Sci. Rep. 2015. Vol. 5. P. 15272. doi: 10.1038/ srep15272.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Kutikhin A.G., Velikanova E.A., Mukhamadiyarov R.A. et al. Apoptosis-mediated endothelial toxicity but not direct calcification or functional changes in anti-calcification proteins defines pathogenic effects of calcium phosphate bions. Sci. Rep. 2016. Vol. 6. P. 27255. doi: 10.1038/srep27255.</mixed-citation><mixed-citation xml:lang="en">Kutikhin A.G., Velikanova E.A., Mukhamadiyarov R.A. et al. Apoptosis-mediated endothelial toxicity but not direct calcification or functional changes in anti-calcification proteins defines pathogenic effects of calcium phosphate bions. Sci. Rep. 2016. Vol. 6. P. 27255. doi: 10.1038/srep27255.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Gimbrone M.A. Jr., Garcia-Cardena G. Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis. Circ. Res. 2016. Vol. 118. No. 4. P. 620-636. doi: 10.1161/ CIRCRESAHA.115.306301.</mixed-citation><mixed-citation xml:lang="en">Gimbrone M.A. Jr., Garcia-Cardena G. Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis. Circ. Res. 2016. Vol. 118. No. 4. P. 620-636. doi: 10.1161/ CIRCRESAHA.115.306301.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Cahill P.A., Redmond E.M. Vascular endothelium - Gatekeeper of vessel health. Atherosclerosis. 2016. Vol. 248. P. 97-109. doi: 10.1016/j.atherosclerosis.2016.03.007.</mixed-citation><mixed-citation xml:lang="en">Cahill P.A., Redmond E.M. Vascular endothelium - Gatekeeper of vessel health. Atherosclerosis. 2016. Vol. 248. P. 97-109. doi: 10.1016/j.atherosclerosis.2016.03.007.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Jensen H.A., Mehta J.L. Endothelial cell dysfunction as a novel therapeutic target in atherosclerosis. Expert Rev. Cardiovasc. Ther. 2016. Vol. 14. No. 9. P. 1021-1033. doi: 10.1080/14779072.2016.1207527.</mixed-citation><mixed-citation xml:lang="en">Jensen H.A., Mehta J.L. Endothelial cell dysfunction as a novel therapeutic target in atherosclerosis. Expert Rev. Cardiovasc. Ther. 2016. Vol. 14. No. 9. P. 1021-1033. doi: 10.1080/14779072.2016.1207527.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Young J.D., Martel J., Young D. et al. Characterization of granulations of calcium and apatite in serum as pleomorphic mineralo-protein complexes and as precursors of putative nanobacteria. PLoS One. 2009. Vol. 4. No. 5. P. e5421. doi: 10.1371/journal.pone.0005421.</mixed-citation><mixed-citation xml:lang="en">Young J.D., Martel J., Young D. et al. Characterization of granulations of calcium and apatite in serum as pleomorphic mineralo-protein complexes and as precursors of putative nanobacteria. PLoS One. 2009. Vol. 4. No. 5. P. e5421. doi: 10.1371/journal.pone.0005421.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Tedgui A, Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol. Rev. 2006. Vol. 86. No. 2. P. 515-581. doi: 10.1152/physrev.00024.2005.</mixed-citation><mixed-citation xml:lang="en">Tedgui A, Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol. Rev. 2006. Vol. 86. No. 2. P. 515-581. doi: 10.1152/physrev.00024.2005.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Kleemann R., Zadelaar S., Kooistra T. Cytokines and atherosclerosis: a comprehensive review of studies in mice. Cardiovasc. Res. 2008. Vol. 79. No. 3. P. 360-376. doi: 10.1093/cvr/cvn120.</mixed-citation><mixed-citation xml:lang="en">Kleemann R., Zadelaar S., Kooistra T. Cytokines and atherosclerosis: a comprehensive review of studies in mice. Cardiovasc. Res. 2008. Vol. 79. No. 3. P. 360-376. doi: 10.1093/cvr/cvn120.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Ait-Oufella H., Taleb S., Mallat Z, Tedgui A. Recent advances on the role of cytokines in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2011. Vol. 31. No. 5. P. 969-979. doi: 10.1161/ATVBAHA.110.207415.</mixed-citation><mixed-citation xml:lang="en">Ait-Oufella H., Taleb S., Mallat Z, Tedgui A. Recent advances on the role of cytokines in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2011. Vol. 31. No. 5. P. 969-979. doi: 10.1161/ATVBAHA.110.207415.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Ramji D.P., Davies T.S. Cytokines in atherosclerosis: Key players in all stages of disease and promising therapeutic targets. Cytokine Growth Factor Rev. 2015. Vol. 26. No. 6. P. 673-685. doi: 10.1016/j.cytogfr.2015.04.003.</mixed-citation><mixed-citation xml:lang="en">Ramji D.P., Davies T.S. Cytokines in atherosclerosis: Key players in all stages of disease and promising therapeutic targets. Cytokine Growth Factor Rev. 2015. Vol. 26. No. 6. P. 673-685. doi: 10.1016/j.cytogfr.2015.04.003.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Moss J.W., Ramji D.P. Cytokines: roles in atherosclerosis disease progression and potential therapeutic targets. Future Med. Chem. 2016. Vol. 8. No. 11. P. 1317-1330. doi: 10.4155/ fmc-2016-0072.</mixed-citation><mixed-citation xml:lang="en">Moss J.W., Ramji D.P. Cytokines: roles in atherosclerosis disease progression and potential therapeutic targets. Future Med. Chem. 2016. Vol. 8. No. 11. P. 1317-1330. doi: 10.4155/ fmc-2016-0072.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Edgell C.J., McDonald C.C., Graham J.B. Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc. Natl. Acad. Sci. U S A. 1983. Vol. 80. No. 12. P. 3734-3737.</mixed-citation><mixed-citation xml:lang="en">Edgell C.J., McDonald C.C., Graham J.B. Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc. Natl. Acad. Sci. U S A. 1983. Vol. 80. No. 12. P. 3734-3737.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Aghagolzadeh P., Bachtler M., Bijarnia R. et al. Calcification of vascular smooth muscle cells is induced by secondary calciprotein particles and enhanced by tumor necrosis factor-а. Atherosclerosis. 2016. Vol. 251. P. 404-414. doi: 10.1016/j.atherosclerosis.2016.05.044.</mixed-citation><mixed-citation xml:lang="en">Aghagolzadeh P., Bachtler M., Bijarnia R. et al. Calcification of vascular smooth muscle cells is induced by secondary calciprotein particles and enhanced by tumor necrosis factor-а. Atherosclerosis. 2016. Vol. 251. P. 404-414. doi: 10.1016/j.atherosclerosis.2016.05.044.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Smith E.R., Hanssen E., McMahon L.P., Holt S.G. Fetuin-A-containing calciprotein particles reduce mineral stress in the macrophage. PLoS One. 2013. Vol. 8. No. 4. P. e60904. doi: 10.1371/journal.pone.0060904.</mixed-citation><mixed-citation xml:lang="en">Smith E.R., Hanssen E., McMahon L.P., Holt S.G. Fetuin-A-containing calciprotein particles reduce mineral stress in the macrophage. PLoS One. 2013. Vol. 8. No. 4. P. e60904. doi: 10.1371/journal.pone.0060904.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Peng H.H., Wu C.Y., Young D. et al. Physicochemical and biological properties of biomimetic mineralo-protein nanoparticles formed spontaneously in biological fluids. Small. 2013. Vol. 9. No. 13. P. 2297-2307. doi: 10.1002/ smll.201202270.</mixed-citation><mixed-citation xml:lang="en">Peng H.H., Wu C.Y., Young D. et al. Physicochemical and biological properties of biomimetic mineralo-protein nanoparticles formed spontaneously in biological fluids. Small. 2013. Vol. 9. No. 13. P. 2297-2307. doi: 10.1002/ smll.201202270.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
